Release of financial calendar for 2025
Investor News
14 November 2024
Release of financial calendar for 2025
| 04 February | Deadline for receipt of resolutions for the Annual General Meeting | |
| 21 February | 2024 Annual Report | |
| 19 March | Annual General Meeting | |
| 09 May | Interim Report, Q1 2025 | |
| 15 August | Interim Report, Q2 2025 | |
| 19 November | Interim Report, Q3 2025 |
Contact
Investors
Jacob Johansen, Head of Investor Relations
+45 2169 3591 / [email protected]
Press
Louise Westh Naldal, Head of Group Communications
+45 2982 0022 / [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
- Hepatic Encephalopathy Therapeutics Market Size in the 7MM is projected to grow at a CAGR of ~1.5% over the forecast period of 2026-2042 | DelveInsight
- Shiba Inu Price Prediction: SHIB Bulls Target a Recovery as Remittix Approaches Its Final Presale Phase
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share